How Do You Build a Start-Up into a $600 Million Exit? We Ask Matt Likens, Former CEO of Ulthera
Jul 7, 2016
40:05
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company public? Or accept a lucrative buyout? Hear from the CEO how the company’s culture and approach led to that favorable outcome.
Medtech Talk